Rare
lephants
Screener
Toggle theme
LifeVantage Corporation
LFVN
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Total Cash from Operations:
$6.6M
Line Item
Value
% of Total
Capital Expenditures
$1.1M
16.0%
Other Financing
$2.0M
29.7%
Other
$9.0K
0.1%
Net Cash Flow
$3.6M
54.2%
Download CSV
